ڤاتوڤيسيولوڬي كسرطان paru-paru merujuk pada perubahan dalam proses fisiologis normal dan mekanisme yang terjadi dalam perkembangan dan perkembangan kanker paru-paru.
patofisiologi jenis kanker paru-paru ini dapat berbeda, karena mereka memiliki mutasi genetik yang berbeda dan merespon secara berbeda terhadap pengobatan.
patofisiologi kanker paru-paru adalah proses yang kompleks dan dinamis, dan peneliti secara terus menerus bekerja untuk lebih memahami mekanisme dasar untuk mengembangkan pengobatan yang lebih efektif dan meningkatkan hasil pasien.
Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W: Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. iScience. 2020, 23 (8): 101411.
Nurwidya F, Syahruddin E, Yunus F: Pain management in lung cancer. Adv Respir Med. 2016, 84 (6): 331-336.
Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, Burke L, Henry MT: Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193 (1): 71-7.
Paramanantham A, Asfiya R, Das S, McCully G, Srivastava A: Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. Int J Mol Sci. 2022, 23 (21): .
Lee D, Kim Y, Chung C: Scientific Validation and Clinical Application of Lung Cancer Organoids. Cells. 2021, 10 (11): .
Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C: Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment. Curr Pharm Des. 2016, 22 (14): 2160-9.
['Slalu seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Jika anda pikir anda mungkin mengalami keadaan darurat medis, hubungi 911 atau pergi ke ruang gawat darurat terdekat segera. Tidak ada hubungan dokter-pasien yang dibuat oleh situs web ini atau penggunaannya. BioMedLib maupun karyawannya, maupun kontributor situs web ini, tidak membuat representasi apapun, secara eksplisit atau implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya. BioMedLib tidak akan memberikan jaminan, baik secara eksplisit maupun implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya. BioMedLib tidak akan memberikan jaminan, baik secara eksplisit maupun implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya. BioMedLib tidak akan memberikan jaminan, baik secara eksplisit maupun implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya.']
['ڤڠهادڤن: حق ڤنوليس']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) ممبري ڤڠاجرن اونتوق ڤميمڤين حق ڤنوليس يڠ مڠڬنتيكن بهاوا ماتريال يڠ دڤرچايا?? ي د انتارنيت مڠڬوناكن حقڽ دالم ڤرلمباڬان حق ڤنوليس اميريكا.']
['(5) pernyataan awak, ditandatangani di bawah hukuman sumpah palsu, bahwa informasi dalam pemberitahuan adalah akurat dan awak memiliki wewenang untuk menegakkan hak cipta yang diklaim dilanggar; ']
['Tulung kirimi kami email dengan pertanyaan/usulan apapun.']
What is pathophysiology of lung cancer?
The pathophysiology of lung cancer refers to the changes in the normal physiological processes and mechanisms that occur in the development and progression of lung cancer.
Lung cancer is a complex disease that arises from the uncontrolled growth and division of abnormal cells in the lungs.
These cells can form tumors and spread to other parts of the body, leading to various symptoms and complications.
The pathophysiology of lung cancer involves several factors, including genetic mutations, environmental factors, and lifestyle choices.
Genetic mutations can occur in the DNA of lung cells, leading to uncontrolled cell growth and division.
These mutations can be inherited or acquired, and they can be caused by exposure to carcinogens, such as tobacco smoke, radon, asbestos, and air pollution.
Lung cancer can be classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is further divided into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
The pathophysiology of these types of lung cancer can differ, as they have different genetic mutations and respond differently to treatment.
The pathophysiology of lung cancer also involves the interaction between cancer cells and the surrounding tissue, including the immune system.
Cancer cells can evade the immune system, allowing them to grow and spread unchecked.
Additionally, the tumor microenvironment can promote tumor growth and metastasis by providing a supportive environment for cancer cells.
The pathophysiology of lung cancer is a complex and dynamic process, and researchers are continuously working to better understand the underlying mechanisms to develop more effective treatments and improve patient outcomes.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['ڤد']
['BioMedLib manggunoan komputer otomatis (algoritma pembelajaran mesin) untok menghasilkan pasangan soal dan jawaban.']
